Lv21
180 积分 2021-08-26 加入
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
2小时前
待确认
Assessment of an automated Cytomegalovirus nucleic acid amplification test using clinical plasma, bronchoalveolar lavage, and tissue specimens
1个月前
已完结
Manganese-independent Reverse Transcriptase Activity of Tth DNA Polymerase with Two Amino Acid Substitutions
3个月前
已完结
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
4个月前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
5个月前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
5个月前
已完结
Concurrent olaparib and radiotherapy in elderly patients with newly diagnosed glioblastoma: the phase I dose escalation PARADIGM trial
7个月前
已完结
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer
7个月前
已完结
Uses of GFR and Albuminuria Level in Acute and Chronic Kidney Disease
8个月前
已完结
Toxicity and response criteria of the Eastern Cooperative Oncology Group
8个月前
已完结
皖公网安备34019202002308
